Stay updated on GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial

Sign up to get notified when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T14:13:45.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:11:41.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision indicator changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:48:01.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden response instead of the study details, indicating access restriction to the study record.
    Difference
    0.5%
    Check dated 2026-09-28T18:11:50.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content and navigation with an access-denied message. This blocks viewing the study details and related sections.
    Difference
    17%
    Check dated 2026-09-21T20:31:15.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a newer version of the page.
    Difference
    0.1%
    Check dated 2026-08-31T18:29:19.000Z thumbnail image

Stay in the know with updates to GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GX-I7 and Pembrolizumab in R/R TNBC Clinical Trial page.